Relafen 750, chemically identified as naproxol, showcases a fascinating case study from a biochemical pharmacy viewpoint. Its action of diminishing inflammation involves the selective inhibition of cyclooxygenase-2 (COX-2), an enzyme essential for the creation of prostanoids, potent agents of inflammation and pain. Unlike traditional NSAIDs, Relafe